Analysis of older adults visiting the emergency department with fever as a suspected Covid-19 vaccine-related adverse reaction: A retrospective multicenter studyObservational Study Published on 2022-08-012022-10-05 Journal: Journal of infection and chemotherapy : official j [Category] 임상, [키워드] Admission Adults Adverse Adverse reaction Adverse reactions age Clinical data clinical feature collected conducted COVID-19 COVID-19 vaccination COVID-19 vaccine Emergency emergency department febrile female Fever Imaging tests initiated investigated Laboratory less medical condition Medical conditions medical records medical service Older older adult Older adults Patient patients postvaccination presenting reported required retrospective Retrospective multicenter study rigor selected the median [DOI] 10.1016/j.jiac.2022.04.022 PMC 바로가기 [Article Type] Observational Study
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccineBNT162b2 mRNA 백신 2회 접종 후 6개월 동안 일본 의료 종사자의 항체 역가 및 세포 면역의 역학Article Published on 2022-07-302022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] All participant All participants Analysis antibody Antibody titer Antibody titers Asymptomatic BNT162b2 BNT162b2 mRNA BNT162b2 vaccine Breakthrough infection breakthrough infections Cellular immune response cellular immune responses cellular immunity clinical trial collected conducted COVID-19 determinant determinants determine dose Dynamics elevated follow-up period healthcare healthcare worker Healthcare workers humoral IgG immune response immune responses incidence Japanese knowledge medical condition Medical conditions mRNA vaccine mRNA vaccines Nucleocapsid proteins of BNT162b2 participant Pfizer Pfizer-BioNTech positive prospective cohort study receiving SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine seroconverted serum sample serum samples study period T-cell immune response T-cell immune responses timepoint vaccination Vaccine waned were measured within 6 months [DOI] 10.1016/j.vaccine.2022.06.016 PMC 바로가기 [Article Type] Article
Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine DoseObservational Study Published on 2022-07-012022-10-04 Journal: Emerging Infectious Diseases [Category] 임상, [키워드] acute respiratory syndrome adverse effects BNT162b2 BNT162b2 mRNA booster booster dose Booster vaccine clinical trials conducted coronavirus coronavirus disease Coronaviruses COVID-19 evaluate first dose greater heart rate variability measure Medical conditions mRNA participant performed Perspective Pfizer-BioNTech Physiologic physiologic reactions prospective observational study questionnaire reaction recorded reported respiratory infections SARS-CoV-2 second dose self-reported reactions severe acute respiratory syndrome coronavirus 2 smartwatch Subjective Support supported systemic reaction third COVID-19 dose vaccination Vaccine vaccine dose Variability viruses wearables zoonoses [DOI] 10.3201/eid2807.212330 PMC 바로가기 [Article Type] Observational Study
Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in VietnamResearch article Published on 2022-07-012022-10-05 Journal: Pediatrics and neonatology [Category] COVID19(2023년), SARS, 임상, [키워드] abdominal pain acute phase acute respiratory syndrome acute SARS-CoV-2 infection addition Admission analyzed Asymptomatic cardiovascular cardiovascular injury children children with MIS-C city clinical feature clinical history clinical manifestations coronavirus coronavirus disease COVID-19 death duration of hospitalization echocardiography Fever Gastrointestinal symptom had no Ho Chi Minh Infection Inflammatory Inflammatory marker Injury Intravenous immunoglobulin Laboratory Long-term follow-up management median age Medical conditions Methylprednisolone MIS-C MOST Most patient Myocardial occurred outcome Patient patients presenting recommendation Result retrospective cohort study returned SARS-CoV-2 stools symptom onset symptomatic syndrome Treatment underlying conditions vomiting [DOI] 10.1016/j.pedneo.2022.05.009 [Article Type] Research article
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization오미크론 변이체로 인한 심각한 COVID-19 질병에 대한 백신 효과 평가. 세계보건기구 회의 보고서Article Published on 2022-06-092022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] approach Assessing average caused COVID-19 COVID-19 disease disease distress Effectiveness evade Evidence faster Health Organization Hospital admission Hospitalization Humoral immunity ICU admission in some Indicator Infection intrinsic measure mechanical ventilation Medical conditions occur omicron Omicron variant outcome oxygen Oxygen requirement Prevalence progression report respiratory distress SARS-CoV-2 second severe COVID-19 disease severe disease severity shown South Africa symptomatic disease The United States to define United Kingdom United States Vaccine vaccine effectiveness Variability variant variants World Health Organization [DOI] 10.1016/j.vaccine.2022.04.069 PMC 바로가기 [Article Type] Article
Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series1차 시리즈를 받은 요양원 거주자 중 mRNA COVID-19 백신 3차 접종 후 부작용Article Published on 2022-06-012022-09-11 Journal: Journal of the American Geriatrics Society [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CI adjust Administered administration Adverse adverse event adverse events adverse events after vaccination booster booster COVID-19 vaccination booster dose CDC COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines dose Electronic health record Electronic health records event event rate event rates false discovery rate genesis Ischemic Stroke medical condition Medical conditions mRNA mRNA vaccine multiple comparisons multiplicity no significant differences nursing home nursing homes occurred prospective cohort reported resident Safety screened significant difference significant differences statistically significant tested vaccination rate venous Venous Thromboembolism [DOI] 10.1111/jgs.17812 PMC 바로가기 [Article Type] Article
Preclinical trial of noncontact anthropometric measurement using IR-UWB radar Research Published on 2022-05-172022-10-05 Journal: Scientific Reports [Category] 임상, [키워드] Algorithm Analysis BMI body mass index children CNN disorders enrolled estimate feasibility growth healthy Infant Infectious disease Intraclass correlation coefficient Malnutrition Medical conditions obesity parameter Preclinical predicted profile Support Transmission Trial [DOI] 10.1038/s41598-022-12209-1 [Article Type] Research
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study건강한 성인에서 AS03 보조제 SARS-CoV-2 재조합 단백질 백신(CoV2 preS dTM)의 안전성 및 면역원성: 2상, 무작위, 용량 찾기, 다기관 연구의 중간 결과Clinical Trial Published on 2022-05-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 95% CI abstinence adjuvants Adults adverse event adverse events Adverse reaction Adverse reactions age All participant All participants antibody Antibody titre Antigen AS03 assessments assigned authority baseline booster vaccination candidate vaccine Chemotherapy childbearing potential clinical development Clinical research clinical trial Cohort Contraception COVID-19 vaccine D614G variant development dose effective Endpoint enrolled evaluated expected fixed Frequency geometric mean geometric mean titre GMT GMT ratio GMTs groups healthy High dose High-dose high-dose group Immunocompromised immunogenicity increase in increased risk injection injection site Injections intensity interim results investigator investigators involved Laboratory lactating low dose low-dose medical condition Medical conditions medium medium dose Mild mild to moderate moderate multicentre Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres occurred Older Older adults Organ transplant outcome outcome assessor outcome assessors parallel-group participant Participants Phase 2 Phase 3 positive prefusion pregnant primary immunogenicity progression proportion Protein protocol provided pseudovirus neutralisation assay randomised Randomly reactogenicity receive Registered reported Research research and development responses robust Safety safety analysis safety endpoints safety profile Sanofi Pasteur SARS-CoV-2 second dose second vaccination selected Serious Adverse Event Serious Adverse Events serodiagnostic Seven severe COVID-19 Stratification study period supported systemic test result titre titres Treatment treatment group treatment groups Trial USA vaccination Vaccine was done were excluded were measured yes or no [DOI] 10.1016/S1473-3099(21)00764-7 PMC 바로가기 [Article Type] Clinical Trial
Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 – COVID-NET, 14 States, March 2020-February 2022실험실에서 확인된 COVID-19로 5-11세 아동의 입원 - COVID-NET, 14개 주, 2020년 3월-2022년 2월Article Published on 2022-04-222022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, [키워드] accounted affected age all age groups analyzed authorization B.1.1.529 black cause CDC Characteristics children Committee conditions Coverage COVID-19 COVID-19 vaccine Critical cumulative diabete diabetes drug Emergency Emergency use authorization food Food and Drug Administration group had no Health highlight Hospitalization Hospitalized ICU Increasing intensive care intensive care unit Medical conditions network obesity omicron outcomes pandemic Pfizer-BioNTech Practice predominant proportion Racial rapid increase severe COVID-19 The United States United States vaccination variant of SARS-CoV-2 virus Year [DOI] 10.15585/mmwr.mm7116e1 PMC 바로가기 [Article Type] Article
Is pregnancy a risk factor for in-hospital mortality in reproductive-aged women with SARS-CoV-2 infection? A nationwide retrospective observational cohort studyObservational Study Published on 2022-04-012022-10-05 Journal: International journal of gynaecology and obstetric [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome adjusted age Analysis analyzed Brazil calculated Characteristics Co-infection coronavirus coronavirus disease coronavirus disease-2019 covariate COVID-19 database Factor favorable effect gestation hazard ratio hypothetical Immunosuppressed In-hospital death in-hospital mortality independent Infection inhibit Intervention lower risk Medical conditions Mortality multivariate Cox regression multivariate logistic regression Observational cohort study Odds ratio polymerase chain Pregnancy pregnant pregnant women Proinflammatory cytokine protective role reproductive retrospective risk factor SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome coronavirus 2 shown sociodemographic factors survival weaker immune response women [DOI] 10.1002/ijgo.14066 PMC 바로가기 [Article Type] Observational Study